CHEN JIN-LONG 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Mar 6, 2023
Insider Transaction Report
Form 4
CHEN JIN-LONG
DirectorChief Scientific Officer
Transactions
- Award
Common Stock
2023-03-02+64,000→ 972,893 total - Award
Stock Option (Right to Buy)
2023-03-02+192,000→ 192,000 totalExercise: $4.36Exp: 2033-03-01→ Common Stock (192,000 underlying) - Award
Stock Option (Right to Buy)
2023-03-02+175,000→ 175,000 totalExercise: $4.36Exp: 2033-03-01→ Common Stock (175,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027.
- [F2]The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis.
- [F3]1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the "2023 Grant Date"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date.